BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hartwig MG, Patel V, Palmer SM, Cantu E, Appel JZ, Messier RH, Davis RD. Hepatitis B Core Antibody Positive Donors as a Safe and Effective Therapeutic Option to Increase Available Organs for Lung Transplantation: . Transplantation 2005;80:320-5. [DOI: 10.1097/01.tp.0000165858.86067.a2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Mone T, Orlowski JP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, Kumar D. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant. 2015;15:1162-1172. [PMID: 25707744 DOI: 10.1111/ajt.13187] [Cited by in Crossref: 133] [Cited by in F6Publishing: 101] [Article Influence: 19.0] [Reference Citation Analysis]
2 Attia M, Silva MA, Mirza DF. The marginal liver donor--an update. Transpl Int. 2008;21:713-724. [PMID: 18492121 DOI: 10.1111/j.1432-2277.2008.00696.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
3 Mahboobi N, Tabatabaei S, Blum H, Alavian S. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature. Transpl Infect Dis 2012;14:445-51. [DOI: 10.1111/j.1399-3062.2012.00782.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
4 Sekar B, Newton PJ, Williams SG, Shaw SM. Should we consider patients with coexistent hepatitis B or C infection for orthotopic heart transplantation? J Transplant 2013;2013:748578. [PMID: 24307939 DOI: 10.1155/2013/748578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Seem DL, Lee I, Umscheid CA, Kuehnert MJ; United States Public Health Service. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep 2013;128:247-343. [PMID: 23814319 DOI: 10.1177/003335491312800403] [Cited by in Crossref: 158] [Cited by in F6Publishing: 127] [Article Influence: 17.6] [Reference Citation Analysis]
6 Chamorro C, Aparicio M. Influence of Anti-HBc Positive Organ Donor in Lung Donor Selection. Archivos de Bronconeumología (English Edition) 2012;48:320-4. [DOI: 10.1016/j.arbr.2012.06.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Fytili P, Ciesek S, Manns MP, Wedemeyer H, Neipp M, Helfritz F, Klempnauer J, Bara C, Haverich A. Anti-HBc Seroconversion after Transplantation of Anti-HBc Positive Nonliver Organs to Anti-HBc Negative Recipients. Transplantation 2006;81:808-9. [DOI: 10.1097/01.tp.0000198585.51562.57] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
8 Chamorro C, Aparicio M. Influence of anti-HBc positive organ donor in lung donor selection. Arch Bronconeumol 2012;48:320-4. [PMID: 22709511 DOI: 10.1016/j.arbres.2012.04.025] [Reference Citation Analysis]
9 Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, Byrnes MC, DeVita MA, Grissom TE, Halpern SD. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med. 2015;43:1291-1325. [PMID: 25978154 DOI: 10.1097/ccm.0000000000000958] [Cited by in Crossref: 171] [Cited by in F6Publishing: 50] [Article Influence: 24.4] [Reference Citation Analysis]
10 Gonzalez SA, Trotter JF. The rise of the opioid epidemic and hepatitis C-positive organs: A new era in liver transplantation: Gonzalez and Trotter. Hepatology 2018;67:1600-8. [DOI: 10.1002/hep.29572] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
11 Routh D, Naidu S, Sharma S, Ranjan P, Godara R. Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. J Clin Exp Hepatol. 2013;3:337-346. [PMID: 25755521 DOI: 10.1016/j.jceh.2013.11.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
12 Manickam P, Krishnamoorthi R, Kanaan Z, Gunasekaran P, Cappell M. Prognostic implications of recipient or donor hepatitis B seropositivity in thoracic transplantation: analysis of 426 hepatitis B surface antigen-positive recipients. Transpl Infect Dis 2014;16:597-604. [DOI: 10.1111/tid.12256] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
13 Estenne M, Kotloff RM. Update in transplantation 2005. Am J Respir Crit Care Med 2006;173:593-8. [PMID: 16522764 DOI: 10.1164/rccm.2601012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
14 Pêgo-Fernandes PM, Samano MN, Fiorelli AI, Fernandes LM, Camargo SM, Xavier AM, Sarmento PA, Bernardo WM, de Castro MC, Jatene FB. Recommendations for the use of extended criteria donors in lung transplantation. Transplant Proc 2011;43:216-9. [PMID: 21335191 DOI: 10.1016/j.transproceed.2010.12.050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
15 Sass DA, Reich DJ. Liver transplantation in the 21st century: expanding the donor options. Gastroenterol Clin North Am. 2011;40:641-658. [PMID: 21893278 DOI: 10.1016/j.gtc.2011.06.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
16 Zhou K, Zhou S. Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors. Curr Opin Organ Transplant 2020;25:631-9. [PMID: 33027191 DOI: 10.1097/MOT.0000000000000810] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wells JT, Lucey MR, Said A. Hepatitis C in transplant recipients of solid organs, other than liver. Clin Liver Dis. 2006;10:901-917. [PMID: 17164124 DOI: 10.1016/j.cld.2006.08.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
18 Englum BR, Ganapathi AM, Speicher PJ, Gulack BC, Snyder LD, Davis RD, Hartwig MG. Impact of donor and recipient hepatitis C status in lung transplantation. J Heart Lung Transplant 2016;35:228-35. [PMID: 26615769 DOI: 10.1016/j.healun.2015.10.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
19 Kim H, Choi J. Prophylaxis for Hepatitis B Core Antibody-Positive Donors after Liver Transplantation. J Korean Soc Transplant 2010;24:73. [DOI: 10.4285/jkstn.2010.24.2.73] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Khemichian S, Kahn J, Terrault NA. Use of Hepatitis B Virus-Positive Organs in Organ Transplantation. Clin Liver Dis 2021;25:841-57. [PMID: 34593157 DOI: 10.1016/j.cld.2021.06.009] [Reference Citation Analysis]
21 Abdala E, Azevedo LS, Avelino-Silva VI, Costa SF, Caramori ML, Strabelli TM, Pierrotti LC, Marques HH, Marques da Silva HH, Lopes MH, Varkulja GF, Santos VA, Shikanai-Yasuda MA; Comissão de Infecção em Imunodeprimidos, Hospital das Clínicas da Faculdade de Medicina da USP. Assessment of organ transplants from donors with markers of hepatitis B. Clinics (Sao Paulo) 2012;67:399-404. [PMID: 22522767 DOI: 10.6061/clinics/2012(04)15] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Russo FP, Viganò M, Stock P, Ferrarese A, Pugliese N, Burra P, Aghemo A. HBV-positive and HIV-positive organs in transplantation: a clinical guide for the hepatologist. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.007] [Reference Citation Analysis]
23 Dhillon GS, Levitt J, Mallidi H, Valentine VG, Gupta MR, Sista R, Weill D. Impact of Hepatitis B Core Antibody Positive Donors in Lung and Heart-Lung Transplantation: An Analysis of the United Network for Organ Sharing Database. Transplantation 2009;88:842-6. [DOI: 10.1097/tp.0b013e3181b4e1fd] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
24 Galar A, Engelson BA, Kubiak DW, Licona JH, Boukedes S, Goldberg HJ, Baden LR, Marty FM, Issa NC. Serologic response to hepatitis B vaccination among lung transplantation candidates. Transplantation 2014;98:676-9. [PMID: 24825523 DOI: 10.1097/TP.0000000000000128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Álvarez-López P, Riveiro-Barciela M, Oleas-Vega D, Flores-Cortes C, Román A, Perelló M, Berastegui C, Castells L, Esteban R, Buti M. Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients. Medicine (Baltimore) 2020;99:e19407. [PMID: 32118794 DOI: 10.1097/MD.0000000000019407] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 White SL, Rawlinson W, Boan P, Sheppeard V, Wong G, Waller K, Opdam H, Kaldor J, Fink M, Verran D, Webster A, Wyburn K, Grayson L, Glanville A, Cross N, Irish A, Coates T, Griffin A, Snell G, Alexander SI, Campbell S, Chadban S, Macdonald P, Manley P, Mehakovic E, Ramachandran V, Mitchell A, Ison M. Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission. Transplant Direct 2019;5:e416. [PMID: 30656214 DOI: 10.1097/TXD.0000000000000852] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]